Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$112M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$79.6M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$41.3M |
| 4 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$24.6M |
| 5 |
Global Payments
GPN
|
+$23M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$104M |
| 2 |
IHS
IHS INC CL-A COM STK
IHS
|
+$30.4M |
| 3 |
Pfizer
PFE
|
+$25.8M |
| 4 |
H&R Block
HRB
|
+$23.6M |
| 5 |
Quest Diagnostics
DGX
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.51% |
| 2 | Healthcare | 11.03% |
| 3 | Industrials | 10.52% |
| 4 | Consumer Discretionary | 7.22% |
| 5 | Financials | 4.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CVD
151
DELISTED
COVANCE INC.
CVD
| $1.35M | 0.05% |
15,836
+8,536
| +117% | +$761K |
|
152
GE Aerospace
GE
$361B
| $1.35M | 0.05% |
10,722
-41,548
| -79% | -$5.28M |
|
|
TECD
153
DELISTED
Tech Data Corp
TECD
| $1.32M | 0.05% |
21,115
+8,715
| +70% | +$540K |
|
154
Conagra Brands
CAG
$7.89B
| $1.31M | 0.05% |
56,914
+19,767
| +53% | +$478K |
|
155
Reinsurance Group of America
RGA
$15.9B
| $1.3M | 0.05% |
16,420
+8,120
| +98% | +$633K |
|
156
Zimmer Biomet
ZBH
$19.3B
| $1.29M | 0.05% |
12,844
-1,450
| -10% | -$141K |
|
157
Spire
SR
$4.78B
| $1.28M | 0.05% |
26,457
+18,821
| +246% | +$880K |
|
158
Trinity Industries
TRN
$2.37B
| $1.27M | 0.05% |
40,488
+17,917
| +79% | +$508K |
|
|
VR
159
DELISTED
Validus Hold Ltd
VR
| $1.27M | 0.05% |
33,182
+23,274
| +235% | +$867K |
|
160
Voya Financial
VOYA
$8.86B
| $1.27M | 0.05% |
34,828
+11,265
| +48% | +$403K |
|
161
Phillips 66
PSX
$96.9B
| $1.26M | 0.05% |
15,732
+8,962
| +132% | +$738K |
|
162
Ameren
AEE
$29.4B
| $1.22M | 0.05% |
+29,829
| New | +$1.19M |
|
163
Progressive
PGR
$127B
| $1.21M | 0.05% |
47,815
+28,507
| +148% | +$706K |
|
164
AT&T
T
$173B
| $1.21M | 0.05% |
45,362
+10,860
| +31% | +$291K |
|
|
KG
165
Kestrel Group
KG
$60.3M
| $1.21M | 0.05% |
5,000
+2,370
| +90% | +$577K |
|
|
HOT
166
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
| $1.19M | 0.05% |
14,713
+6,402
| +77% | +$503K |
|
|
VRNT
167
DELISTED
Verint Systems
VRNT
| $1.17M | 0.04% |
46,708
+35,833
| +329% | +$843K |
|
168
Loews
L
$22.5B
| $1.17M | 0.04% |
26,488
+21,199
| +401% | +$926K |
|
|
BBBY
169
DELISTED
Bed Bath & Beyond Inc
BBBY
| $1.16M | 0.04% |
20,256
+12,216
| +152% | +$762K |
|
170
Lear
LEA
$8.56B
| $1.16M | 0.04% |
12,952
+4,052
| +46% | +$349K |
|
171
Elevance Health
ELV
$86.9B
| $1.14M | 0.04% |
10,629
+629
| +6% | +$64.8K |
|
172
Citigroup
C
$221B
| $1.13M | 0.04% |
24,072
+9,262
| +63% | +$441K |
|
|
ERF
173
DELISTED
Enerplus Corporation
ERF
| $1.13M | 0.04% |
+45,332
| New | +$1M |
|
|
UFS
174
DELISTED
DOMTAR CORPORATION (New)
UFS
| $1.13M | 0.04% |
26,428
+10,228
| +63% | +$479K |
|
175
West Pharmaceutical
WST
$24.8B
| $1.13M | 0.04% |
26,710
+13,993
| +110% | +$599K |
|
Similar funds
Paul Tudor Jones's Q2 2014 Portfolio in Review
As of Q2 2014, Paul Tudor Jones held 1,510 positions worth $2.61B, up 11% from $2.36B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Paul Tudor Jones deployed $161M of net new capital in Q2 2014, opening 336 new positions and adding to 390 existing holdings. Its largest new stake was Apple: 5,248,200 shares worth $122M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 9.3% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Pfizer, an estimated $25.8M trimmed.
- Paul Tudor Jones's largest Q2 2014 buy was Apple: 5,248,200 shares worth $122M.
- Paul Tudor Jones added most to iShares MSCI Emerging Markets ETF in Q2 2014, an estimated $79.6M increase.
- Paul Tudor Jones's biggest Q2 2014 reduction was Pfizer, cutting an estimated $25.8M.
- Paul Tudor Jones fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2014, selling an estimated $104M.
- Paul Tudor Jones's ten largest holdings make up 46% of its $2.61B portfolio in Q2 2014.
- Paul Tudor Jones opened 336 new positions and closed 367 in Q2 2014.
- Paul Tudor Jones's portfolio value rose 11% quarter-over-quarter to $2.61B.
Based on Tudor Investment Corp's 13F filing for Q2 2014, filed 14 Aug 2014.